Literature DB >> 19487475

Most environmental isolates of Cryptococcus neoformans var. grubii (serotype A) are not lethal for mice.

Anastasia P Litvintseva1, Thomas G Mitchell.   

Abstract

Most cases of cryptococcosis are caused by Cryptococcus neoformans var. grubii (serotype A), which is widespread in the environment, where it is primarily associated with pigeon excreta. A number of molecular epidemiological studies indicate that many environmental and clinical isolates of serotype A are indistinguishable. However, the murine virulence of environmental strains of C. neoformans has not been thoroughly evaluated. We used the murine intranasal model of cryptococcosis to compare the lethality of clinical and environmental strains of serotype A that possessed identical genotypes as determined by amplified fragment length polymorphisms (AFLP) and multilocus sequence typing (MLST). Eleven environmental strains were tested, and only one caused disease within 60 days postinfection, at which time the experiments were terminated. Conversely, 7 of 10 clinical isolates were lethal for mice at median times of 19 to 40 days. Passing environmental isolates in mice (up to three times) did not significantly increase their lethality. In follow-up studies, we developed a new genotyping technique based on hybridization with TCN2 and TCN4 retrotransposon-specific probes. Although the retrotransposon banding patterns were unstable after prolonged incubation in the laboratory, this method was able to differentiate clinical and environmental strains that had the same AFLP/MLST genotypes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19487475      PMCID: PMC2715664          DOI: 10.1128/IAI.00296-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide.

Authors:  D L Goldman; S C Lee; A J Mednick; L Montella; A Casadevall
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  The diversity of retrotransposons in the yeast Cryptococcus neoformans.

Authors:  T J Goodwin; R T Poulter
Journal:  Yeast       Date:  2001-06-30       Impact factor: 3.239

3.  Serologic evidence for Cryptococcus neoformans infection in early childhood.

Authors:  D L Goldman; H Khine; J Abadi; D J Lindenberg; R Niang; A Casadevall
Journal:  Pediatrics       Date:  2001-05       Impact factor: 7.124

4.  Evidence of sexual recombination among Cryptococcus neoformans serotype A isolates in sub-Saharan Africa.

Authors:  Anastasia P Litvintseva; Robert E Marra; Kirsten Nielsen; Joseph Heitman; Rytas Vilgalys; Thomas G Mitchell
Journal:  Eukaryot Cell       Date:  2003-12

5.  Molecular typing of IberoAmerican Cryptococcus neoformans isolates.

Authors:  Wieland Meyer; Alexandra Castañeda; Stuart Jackson; Matthew Huynh; Elizabeth Castañeda
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

Review 6.  'Ready made' virulence and 'dual use' virulence factors in pathogenic environmental fungi--the Cryptococcus neoformans paradigm.

Authors:  Arturo Casadevall; Judith N Steenbergen; Joshua D Nosanchuk
Journal:  Curr Opin Microbiol       Date:  2003-08       Impact factor: 7.934

7.  Serotyping of 467 Cryptococcus neoformans isolates from clinical and environmental sources in Brazil: analysis of host and regional patterns.

Authors:  Marília M Nishikawa; Márcia S Lazera; Glaucia G Barbosa; Luciana Trilles; Beatriz R Balassiano; Regina C L Macedo; Cláudia C F Bezerra; Maurício A Pérez; Paola Cardarelli; Bodo Wanke
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

8.  Staib agar supplemented with a triple antibiotic combination for the detection of Cryptococcus neoformans in clinical specimens.

Authors:  F Staib; M Seibold; E Antweiler; B Fröhlich
Journal:  Mycoses       Date:  1989-09       Impact factor: 4.377

9.  Restriction fragment length polymorphism analysis of Cryptococcus neoformans isolates from environmental (pigeon excreta) and clinical sources in New York City.

Authors:  B P Currie; L F Freundlich; A Casadevall
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

10.  Virulence and antifungal susceptibility of environmental and clinical isolates of Cryptococcus neoformans from Puerto Rico.

Authors:  R A Fromtling; G K Abruzzo; A Ruiz
Journal:  Mycopathologia       Date:  1989-06       Impact factor: 2.574

View more
  35 in total

Review 1.  Investigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How?

Authors:  Alexandre Alanio; Marie Desnos-Ollivier; Dea Garcia-Hermoso; Stéphane Bretagne
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  The Mouse Inhalation Model of Cryptococcus neoformans Infection Recapitulates Strain Virulence in Humans and Shows that Closely Related Strains Can Possess Differential Virulence.

Authors:  Liliane Mukaremera; Tami R McDonald; Judith N Nielsen; Christopher J Molenaar; Andrew Akampurira; Charlotte Schutz; Kabanda Taseera; Conrad Muzoora; Graeme Meintjes; David B Meya; David R Boulware; Kirsten Nielsen
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

Review 3.  Dueling in the lung: how Cryptococcus spores race the host for survival.

Authors:  Michael R Botts; Christina M Hull
Journal:  Curr Opin Microbiol       Date:  2010-08       Impact factor: 7.934

4.  Most cases of cryptococcal meningitis in HIV-uninfected patients in Vietnam are due to a distinct amplified fragment length polymorphism-defined cluster of Cryptococcus neoformans var. grubii VN1.

Authors:  Jeremy N Day; Thu N Hoang; Anh V Duong; Chau T T Hong; Pham T Diep; James I Campbell; Tran P M Sieu; Tran T Hien; Tien Bui; Maciej F Boni; David G Lalloo; Dee Carter; Stephen Baker; Jeremy J Farrar
Journal:  J Clin Microbiol       Date:  2010-12-15       Impact factor: 5.948

5.  Blood-brain barrier invasion by Cryptococcus neoformans is enhanced by functional interactions with plasmin.

Authors:  Jamal Stie; Deborah Fox
Journal:  Microbiology       Date:  2011-10-13       Impact factor: 2.777

6.  Polymyxin B, in combination with fluconazole, exerts a potent fungicidal effect.

Authors:  Bing Zhai; Henry Zhou; Liangpeng Yang; Jun Zhang; Kathy Jung; Chou-Zen Giam; Xin Xiang; Xiaorong Lin
Journal:  J Antimicrob Chemother       Date:  2010-02-18       Impact factor: 5.790

7.  Congenic strains of the filamentous form of Cryptococcus neoformans for studies of fungal morphogenesis and virulence.

Authors:  Bing Zhai; Pinkuan Zhu; Dylan Foyle; Srijana Upadhyay; Alexander Idnurm; Xiaorong Lin
Journal:  Infect Immun       Date:  2013-05-13       Impact factor: 3.441

8.  Altered immune response differentially enhances susceptibility to Cryptococcus neoformans and Cryptococcus gattii infection in mice expressing the HIV-1 transgene.

Authors:  Kassandre Leongson; Vincent Cousineau-Côté; Mathieu Goupil; Francine Aumont; Serge Sénéchal; Louis Gaboury; Paul Jolicoeur; James W Kronstad; Louis de Repentigny
Journal:  Infect Immun       Date:  2013-01-22       Impact factor: 3.441

Review 9.  Cryptococcus: from environmental saprophyte to global pathogen.

Authors:  Robin C May; Neil R H Stone; Darin L Wiesner; Tihana Bicanic; Kirsten Nielsen
Journal:  Nat Rev Microbiol       Date:  2015-12-21       Impact factor: 60.633

10.  Microsatellite typing of clinical and environmental Cryptococcus neoformans var. grubii isolates from Cuba shows multiple genetic lineages.

Authors:  Maria-Teresa Illnait-Zaragozi; Gerardo F Martínez-Machín; Carlos M Fernández-Andreu; Teun Boekhout; Jacques F Meis; Corné H W Klaassen
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.